2m 2m 2m 2m 2m 2m 2m
Mosaic Immn (CPMV)
OTC
$0.11+$0.04 (+73.28%)
Price as of Oct 01, 2026- $765,493.00Market Cap
- -84.88%1-Year Change
- BiotechnologyIndustry
Mosaic Immn (CPMV)
$0.11+$0.04 (+73.28%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 48
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.11
$0.28
$0.11
1-Year Range
$0.05
$1.05
$0.11
Latest Close$0.11
Change
+$0.04 (+42.29%)
Volume637
Market Cap$765,493.00
Shares Outstanding7.2M
Enterprise Value$2.5M
Information as of 10/01/2026
Company Profile
Mosaic ImmunoEngineering Inc.
https://www.mosaicie.com$765,493.00
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
9114 Adams Avenue, Huntington Beach, CA, United States, 92646
657 208 0890Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
Key Executives
- Steven W. King
- Paul J. Lytle
- Cyril Empig
- Marvin R. Garovoy
- Joseph S. Shan
Current Ownership Distribution
- Insiders6.7M (92.45%)
- Other547,064 (7.55%)
- Institutions3 (0.00004%)
- Mutual Funds0 (0.00%)